Back to Journals » Infection and Drug Resistance » Volume 9

Evaluating vancomycin susceptibility in Staphylococcus aureus

Authors Mimica M, Navarini A

Received 14 June 2016

Accepted for publication 20 June 2016

Published 26 September 2016 Volume 2016:9 Pages 239—241

DOI https://doi.org/10.2147/IDR.S114942

Checked for plagiarism Yes

Editor who approved publication: Professor Suresh Antony

Marcelo J Mimica, Alessandra Navarini

Department of Pathology, Division of Microbiology, Santa Casa de São Paulo School of Medicine, São Paulo, Brazil

We read the report by Phillips et al1 with great interest and would like to discuss it in comparison with our previous published data on the subject.2,3
    We have also studied a number of Staphylococcus aureus clinical isolates (n=125), comparing different vancomycin susceptibility tests, including microdilution, Etest® (bio-Mérieux, Marcy-l’Étoile, France), and brain heart infusion vancomycin screening plates. We found only one isolate with reduced susceptibility with a minimum inhibitory concentration (MIC) =4 mg/L when tested with Etest and 2 mg/L when tested with microdilution.2,3 Our results showed a tendency of higher lethality when higher MICs were present, even within the susceptible range,3 as some previous studies have shown.4,5

View original paper by Phillips et al.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]